Merit Medical Systems (MMSI) Cash & Equivalents (2010 - 2026)

Merit Medical Systems (MMSI) has 17 years of Cash & Equivalents data on file, last reported at $488.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 23.4% year-over-year to $488.1 million; the trailing twelve-month figure through Mar 2026 stood at $488.1 million (up 23.4% YoY), and the FY2025 full-year result was $446.4 million, up 18.5% from the prior year.
• Cash & Equivalents improved to $488.1 million in Q1 2026, from $446.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $636.7 million in Q2 2024 to a low of $51.5 million in Q3 2022.
• A 5-year average of $305.0 million and a median of $376.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 905.06% in 2023 and plunged 46.31% in 2025, its largest moves.
• Tracing MMSI's Cash & Equivalents over 5 years: stood at $58.4 million in 2022, then surged by 905.06% to $587.0 million in 2023, then slumped by 35.83% to $376.7 million in 2024, then climbed by 18.5% to $446.4 million in 2025, then grew by 9.34% to $488.1 million in 2026.
• Business Quant data shows MMSI's Cash & Equivalents at $488.1 million in Q1 2026, $446.4 million in Q4 2025, and $392.5 million in Q3 2025.